Cyclosporine for dry eye safe, effective at 2 years
July 1st 2010A final analysis of a 2-year study with cyclosporine ophthalmic emulsion 0.05% used for the treatment of dry eye syndrome shows that patient have continued improvement in their dry eye parameters over a 2-year period, according to one expert.
Judge rejects CIBA's attempt to block J&J contact lens sales
June 1st 2010Johnson & Johnson Vision Care Inc. may continue selling its Acuvue Oasys contact lenses, even though its manufacturing infringes CIBA Vision Corp.'s patent, in order to protect "millions of innocent contact lens wearers" who would have to be refitted with a different brand, a federal judge has ruled.
New gatifloxacin solution offers enhanced formulation
June 1st 2010The availability of a new formulation of gatifloxacin ophthalmic solution containing 0.5% of active ingredient provides optometrists with a valuable option for addressing the growing problem of resistance among some important ocular pathogens.
Device provides controlled drug delivery for treating diabetic macular edema
June 1st 2010Analyses of 24-month data from the two pivotal phase III trials investigating a proprietary fluocinolone acetonide-releasing intravitreal insert for the treatment of diabetic macular edema generated positive results that are the basis for filing a new drug application with the FDA.